GLP Watchdog

GobyMeds vs Oak

Neither GobyMeds nor Oak has an FDA warning letter on record. On brand-name semaglutide pen, Oak costs $4,090 less a year at standing rates: $1,250 a month (billed every 4 weeks) against $1,695 a month at GobyMeds. It is one of three products the two sell at comparable terms.

By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed

The record

GobyMeds / Oak

GobyMeds logo

GobyMeds

7.7/10

Featured pick (affiliate partner)

Oak logo

Oak

7.2/10

FDA warning letters
None on record
None on record
Pharmacy
  • Precision Medicinetype not stated
  • HealthWarehouse.comtype not stated
  • The Pharmacy Hub503A
  • and 1 more
None named in our record
Lowest standing price
$169/moCompounded semaglutide injection
$100/moBrand-name semaglutide pill, billed every 4 weeks
States
No state list published
48 states
Checked
Prices captured Record checked October 2026
Prices captured Record checked October 2026
Visit GobyMedsFull review
Visit OakFull review

Oak is our featured pick on this page because it is an affiliate partner: we are paid if you sign up through our link. GobyMeds pays us nothing. The scores are computed the same way for both and are shown as computed (GobyMeds 7.7, Oak 7.2). How we are paid

What the record shows

  1. 01

    Neither GobyMeds nor Oak has an FDA warning letter on record.

  2. 02

    GobyMeds names four pharmacies. Oak names no compounding pharmacy in our record.

  3. 03

    On brand-name semaglutide pen, Oak costs $4,090 less a year at standing rates: $1,250 a month (billed every 4 weeks) against $1,695 a month at GobyMeds. It is one of three products the two sell at comparable terms.

  4. 04

    Only Oak lists a price for compounded oral semaglutide and brand-name semaglutide pill.

  5. 05

    Oak lists 48 states. GobyMeds publishes no state list.

Prices and terms, product by product

A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.

GobyMeds

Oak

Compounded semaglutide injection

$169/moLower

$2,028 a year

$250/mo

$3,000 a year

Compounded tirzepatide injection

$299/mo

$3,588 a year

$300/mo

$3,600 a year

Brand-name semaglutide pen

$1,695/mo

$20,340 a year

$1,250/moLower

$16,250 a year, 13 charges

Brand-name tirzepatide pen

$1,399/mo

$16,788 a year

$1,200/moLower

$15,600 a year, 13 charges

Compounded oral semaglutide
Not sold or not priced

$260/mo

$3,380 a year, 13 charges

Brand-name semaglutide pill
Not sold or not priced

$100/mo

$1,300 a year, 13 charges

Price includes
Medication, clinician visits, shipping
Medication, shipping, coaching
Cancel any time
Yes, stated
Yes, stated
Minimum term
None; each bundle or month is a one-time purchase
None (3-, 6- and 12-month plans optional)
Refunds
All prescriptions are final sale and non-refundable
No refunds once a provider approves the order
Early-exit fee
None stated
Yes

Read off each seller’s own pages. GobyMeds: October 17, 2026. Oak: October 17, 2026. Every plan and dose we hold is on the full review.

The case for each

The case for GobyMeds

7.7/10
  • $972 a year less on compounded semaglutide injection
  • Names its compounding pharmacy
  • Publishes no state list
Visit GobyMeds

The case for Oak

7.2/10
Featured pick (affiliate partner)
  • $4,090 a year less on brand-name semaglutide pen
  • $1,188 a year less on brand-name tirzepatide pen
  • Sells compounded oral semaglutide and brand-name semaglutide pill, which GobyMeds does not price
  • Names no compounding pharmacy
Visit Oak

Scores

GobyMeds 7.7 · Oak 7.2 out of 10. Six weighted parts.

Value25%

6.2A
vs
B
3.1

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

8.0A
vs
B
8.0

Trust & Safety15%

8.0A
vs
B
7.5

Accessibility10%

5.0A
vs
B
9.7

Support10%

7.0A
vs
B
6.0

The score is the same formula for every seller. Payment does not enter it. Method

GobyMeds vs Oak: questions

Neither GobyMeds nor Oak has an FDA warning letter on record. Letters are matched to a seller by company, domain and address, never by a similar name.
GobyMeds names four pharmacies. Oak names no compounding pharmacy in our record. A 503A pharmacy compounds for named patients on a prescription; a 503B outsourcing facility is registered with FDA and inspected under federal manufacturing rules.
GobyMeds, by $972 a year at standing rates. GobyMeds: $169 a month, about $2,028 a year. Oak: $250 a month, about $3,000 a year.
GobyMeds states you can cancel at any time; refunds: all prescriptions are final sale and non-refundable. Oak states you can cancel at any time; refunds: no refunds once a provider approves the order.
Oak is our featured pick on this page because it is an affiliate partner: we are paid if you sign up through our link. GobyMeds pays us nothing. The scores are computed the same way for both and are shown as computed (GobyMeds 7.7, Oak 7.2).

Other sellers we are paid by

Affiliate partners outside this pair. Each has its own record and review, scored the same way.

Sellers closest to these two

Matched on molecule, form and price. Every pair we list · The register

Brand names on this page are registered marks. Novo Nordisk holds Wegovy®, Ozempic® and Rybelsus®; Eli Lilly holds Zepbound®, Mounjaro® and Foundayo®. Neither company has any tie to GLP Watchdog. Trademarks